Cargando…

Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial

BACKGROUND: There is intense interest about whether modulating gut microbiota can impact systemic metabolism. We investigated the safety of weekly oral fecal microbiota transplantation (FMT) capsules from healthy lean donors and their ability to alter gut microbiota and improve metabolic outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Elaine W., Gao, Liu, Stastka, Petr, Cheney, Michael C., Mahabamunuge, Jasmin, Torres Soto, Mariam, Ford, Christopher B., Bryant, Jessica A., Henn, Matthew R., Hohmann, Elizabeth L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062239/ https://www.ncbi.nlm.nih.gov/pubmed/32150549 http://dx.doi.org/10.1371/journal.pmed.1003051

Ejemplares similares

OR26-06 Fecal Microbiota Transplantation Trial for the Improvement of Metabolism (FMT-TRIM): A Randomized Double-Blind Placebo-Controlled Pilot Trial
por: Yu, Elaine Wei-Yin, et al.
Publicado: (2020)

Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
por: Youngster, Ilan, et al.
Publicado: (2016)

Step-up fecal microbiota transplantation (FMT) strategy
por: Cui, Bota, et al.
Publicado: (2016)

Monkeypox and fecal microbiota for transplantation(FMT): An unprecedented risk?
por: Owais, Rabia, et al.
Publicado: (2022)

Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression—Case Report
por: Doll, Jessica P. K., et al.
Publicado: (2022)

Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection
por: Garza-González, Elvira, et al.
Publicado: (2019)

Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation
por: Zhang, Wanying, et al.
Publicado: (2020)

615. Can We Restore the Lung Microbiome with Fecal Microbiota Transplant (FMT)?
por: Mendez, Roberto, et al.
Publicado: (2018)

Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D
por: Singh, Prashant, et al.
Publicado: (2022)

Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients
por: Moss, Eli L., et al.
Publicado: (2017)

Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
por: Fareed, Shaaz, et al.
Publicado: (2018)

1122. Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)
por: Hassoun, Ali, et al.
Publicado: (2018)

Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis
por: Costello, Samuel Paul, et al.
Publicado: (2020)

Knowledge, attitudes, ethical and social perspectives towards fecal microbiota transplantation (FMT) among Jordanian healthcare providers
por: Al-Bakri, Amal G., et al.
Publicado: (2021)

A48 LYOPHILIZED FECAL MICROBIOTA TRANSPLANT (FMT) DELAYS THE ONSET OF SPONTANEOUS COLITIS IN MUC2-/- MICE
por: Chan, J J, et al.
Publicado: (2023)

Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection
por: Chehri, Mahtab, et al.
Publicado: (2018)

Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient
por: Bloom, Patricia P., et al.
Publicado: (2022)

Durability and Long-Term Clinical Outcomes of Fecal Microbiota Transplant (FMT) Treatment in Patients with Recurrent C. difficile Infection
por: Mamo, Yafet, et al.
Publicado: (2017)

Fecal Microbiota Transplant in Severe and Non-Severe Clostridioides difficile Infection. Is There a Role of FMT in Primary Severe CDI?
por: Popa, Daniel, et al.
Publicado: (2021)

Recurrent Relatively Resistant Salmonella infantis Infection in 2 Immunocompromised Hosts Cleared With Prolonged Antibiotics and Fecal Microbiota Transplantation
por: Torres Soto, Mariam, et al.
Publicado: (2018)

Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series
por: Dang, Xiao-Fei, et al.
Publicado: (2020)

Fecal Microbiota Transplantation (FMT) for Recurrent/Refractory Clostridium difficile Infection (CDI) in Pediatric Immunocompromised Patients: A Single-center Experience
por: Kwendakwema, Natasha, et al.
Publicado: (2017)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

How to Apply FMT More Effectively, Conveniently and Flexible – A Comparison of FMT Methods
por: Varga, Adorján, et al.
Publicado: (2021)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey
por: Baunwall, Simon Mark Dahl, et al.
Publicado: (2021)

Effects of a farm-specific fecal microbial transplant (FMT) product on clinical outcomes and fecal microbiome composition in preweaned dairy calves
por: Slanzon, Giovana S., et al.
Publicado: (2022)

Clinical and Economic Evaluation of commercialized Fecal Microbiota Transplant (cFMT) for Patients with Recurrent Clostridium difficile Infection (CDI) in a Large Community Hospital
por: Hassoun, Ali, et al.
Publicado: (2017)

Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial
por: Zhao, Ye, et al.
Publicado: (2021)

1929. Evaluating Disparities in Recurrent Clostridioides difficile Infection (CDI) and Fecal Microbiota Transplant (FMT) Treatment using Geospatial and Social Vulnerability Analytic Tools
por: Little, Keighly, et al.
Publicado: (2023)

Fecal Microbiota Transplant: Benefits and Risks
por: Weil, Ana A., et al.
Publicado: (2015)

Patient perception and approval of faecal microbiota transplantation (FMT) as an alternative treatment option for obesity
por: Gundling, F., et al.
Publicado: (2018)

Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
por: Airola, Carlo, et al.
Publicado: (2023)

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
por: Fretheim, Håvard, et al.
Publicado: (2020)

Effectiveness of FMT in recurrent Clostridium difficile infection
por: Grzesiowski, P, et al.
Publicado: (2015)

FDA's pathway for regulation of FMT: not so fraught
por: Riley, Margaret F., et al.
Publicado: (2015)

FMT in IBS: how cautious should we be?
por: El-Salhy, Magdy
Publicado: (2021)

Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)
por: Merrick, Blair, et al.
Publicado: (2023)

Hybrid µCT-FMT imaging and image analysis
por: Gremse, Felix, et al.
Publicado: (2015)

1694. Successful Gut Decolonization of Extended-Spectrum β-lactamase Producing Klebsiella pneumoniae Using Oral Lyophilized Fecal Microbiota Transplant (FMT) in a Woman with Recurrent Urinary Tract Infections
por: Bier, Naomi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_22b9o71urdoje4l3pq28fqirb4